*The following content is generated by AI and is for reference only.
Overview
Brivaracetam is a synthetic antiepileptic drug developed as a high-affinity ligand for the synaptic vesicle protein SV2A. Its core manufacturing process involves stereoselective synthesis to ensure optical purity. The compound is identified by the molecular formula C13H18N2O2 and CAS number 264090-75-7.
Application
- Pharmaceutical Manufacturing: Production of adjunctive therapy tablets for partial-onset seizures.
- Research & Development: Use in clinical trials evaluating neuroprotective mechanisms.
- API Supply Chain: Bulk distribution to global formulators for generic drug production.
Precautions
Strictly contraindicated for patients with known hypersensitivity to brivaracetam or levetiracetam. Storage requires controlled room temperature (20°C–25°C) in moisture-proof containers to maintain stability. Personal protective equipment is mandatory during handling to prevent dermal absorption.